Colchicine for the Stability of Coronary Plaque in Acute Coronary Syndrome (COLOCT)

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 128 participants.

Also called NCT04848857

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 128 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT04848857
Other papers using this trial's data
  • Effect of Colchicine on Coronary Plaque Stability in Acute Coronary Syndrome as Assessed by Optical Coherence Tomography: The COLOCT Randomized Clinical Trial Circulation, 2024-09-24 DOI, PubMed 39166327

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
China (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT04848857. Randomized; double masking; primary purpose treatment. Start 2021-05-03 (actual); primary completion 2023-08-20 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Colchicine for the Stability of Coronary Plaque in Acute Coronary Syndrome (COLOCT)
Acronym
COLOCT
Condition
Acute Coronary Syndrome
Intervention (Drug)
Colchicine
Intervention (Drug)
Placebo
Lead sponsor
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology (class: other)

Record details

Record id
cardio:ct-nct04848857
Content hash
f01be81862f56bfd21c08db97f5434366ae5f63a45af2ccaec48520ed43fe055